Ratings Sensient Technologies Corporation

Equities

SXT

US81725T1007

Real-time Estimate Cboe BZX Other stock markets 02:16:36 2024-04-29 pm EDT			5-day change	1st Jan Change
73.31 ^USD	+4.19%		+6.20%	+10.98%

04:29pm	Baird Raises Price Target on Sensient Technologies to $80 From $70, Maintains Outperform Rating	MT
Apr. 26	Transcript : Sensient Technologies Corporation, Q1 2024 Earnings Call, Apr 26, 2024

Summary

From a short-term investment perspective, the company presents a deteriorated fundamental situation

Strengths

Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
Over the past twelve months, analysts' opinions have been strongly revised upwards.
Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.

Weaknesses

With a 2024 P/E ratio at 24.86 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
The company appears highly valued given the size of its balance sheet.
The company is highly valued given the cash flows generated by its activity.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Specialty Chemicals

	1st Jan change	Capi.	ESG Refinitiv
SENSIENT TECHNOLOGIES CORPORATION	+9.84%	2.98B	B
ECOLAB INC.	+11.95%	63.22B	A-
SIKA AG	-3.14%	46.34B	A-
GIVAUDAN SA	+13.49%	39.97B	B+
FUJIFILM HOLDINGS CORPORATION	+17.83%	25.46B	A-
EMS-CHEMIE HOLDING AG	+8.00%	18.68B	C+
CELANESE CORPORATION	+0.82%	17.24B	B+
POSCO FUTURE M CO., LTD.	-21.73%	15.81B	A-
SYMRISE AG	+0.86%	14.9B	B+
ALBEMARLE CORPORATION	-14.06%	13.74B	C+

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes